Market Overview

Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates

Share:
Related UTHR
Biotech: Anatomy Of An Investing Mania?
5 Mid-Cap Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 Years
Related ENDP
3 JPMorgan Bull Calls Hitting The Market
Benzinga's M&A Chatter for Monday March 16, 2015
Lipocine: A Favorable Risk/Reward Profile (Seeking Alpha)

Below are the top drug manufacturers-other stocks on the NASDAQ in terms of earnings estimate for the next year.

United Therapeutics (NASDAQ: UTHR) is likely to earn $6.96 per share in the next year ending December, 2014. United Therapeutics' trailing-twelve-month ROE is 24.83%.

Endo Health Solutions (NASDAQ: ENDP) may earn $3.83 per share in the next year ending December, 2014. Endo Health's trailing-twelve-month revenue is $3.03 billion.

The Medicines Company (NASDAQ: MDCO) is projected to earn $1.15 per share for the next year ending December, 2014. Medicines Company's trailing-twelve-month operating margin is 16.42%.

Cubist Pharmaceuticals (NASDAQ: CBST) is expected to earn $1.14 per share over the next year ending December, 2014. Cubist's trailing-twelve-month ROA is 2.54%.

Posted-In: Drug Manufacturers-Other Industry EPS Estimates NASDAQTrading Ideas

 

Related Articles (CBST + ENDP)

Around the Web, We're Loving...